TY  - GEN
AU  - Chen,Kuen-Feng
AU  - Pao,Kuan-Chuan
AU  - Su,Jung-Chen
AU  - Chou,Yi-Chieh
AU  - Liu,Chun-Yu
AU  - Chen,Hui-Ju
AU  - Huang,Jui-Wen
AU  - Kim,InKi
AU  - Shiau,Chung-Wai
TI  - Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity
SN  - 1464-3391
PY  - 2013///0214
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - drug effects
KW  - Down-Regulation
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Erlotinib Hydrochloride
KW  - Humans
KW  - Protein Phosphatase 2
KW  - Pyrimidines
KW  - chemistry
KW  - Quinazolines
KW  - chemical synthesis
KW  - Structure-Activity Relationship
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.bmc.2012.08.039
ER  -